Objective To discuss the influence of the progress and result in rectal cancer operation through application of neo-adjuvant chemotherapy in multi-disciplinary team (MDT). Methods The patients treated in MDT model and non-MDT model between June to September 2007 were respectively analyzed, and the index about pathologic change, histologic transform and operative result between the two groups were compared.Results In the index of pathologic change, the incidence of abdominal adherence (13.5%, 7/52), ascites (7.7%, 4/52) and latent malignant intestinal obstruction (5.8%, 3/52) in MDT model group were obviously less than non-MDT model group (P=0.000). In the index of histologic transform, texture of mesentery in MDT model group was more fragile than non-MDT model group (P=0.000). The incidence of edema of pelvic tissues in MDT model group were more than non-MDT model group (P=0.000). However, the differences between the incidence of edema of pelvic peritoneum and adherence of mesorectum in two groups were insignificant (Pgt;0.05). In the index of operative results, the operative duration and intra-operative bleeding in MDT model group were less than non-MDT model group (P=0.000). And the protection of pelvic autonomic nerve in MDT model group was better than non-MDT model group (P=0.000). Meanwhile, accuracy rate in prediction of radical resection with anus-preserving in both groups were in high level (92.3% vs 76.2%). Conclusion Neo-adjuvant chemotherapy has certain influence in rectal cancer operation, but the successful operations are performed by standard and correct procedures. Therefore, optimizing combined therapy in MDT model and constructing preoperative evaluation system with neo-adjuvant chemotherapy, would be the next important focus.
Objective To discuss the performance of multi-disciplinary team (MDT) of colorectal cancer treatment within West China Hospital in Sichuan University. Methods To compare the therapeutic effect between groups of MDT model and non-MDT model by retrospectively analyzing the data of patients who diagnosed colorectal cancer and accepted in-hospital therapy during December 2006 and May 2007. Results The in-hospital days of the MDT model group during the perioperative period and in the surgical ward were less than that of the non-MDT model group ( Plt; 0. 05) , but there was no significant difference between the two groups about the total hospitalization time. And the MDT model group had a higher rate of cancer resection ( P lt; 0. 05) . Although the incidence of anastomotic leakage and bleeding as early postoperative complications didn’t show any variations between the two groups , the non-MDT model groupencountered more early postoperative ileus ( Plt; 0. 05) . During the 5－ 10 months follow-up , there came out less cancer recurrence rate in the MDT model group than the other ( P lt; 0. 05) . And the morbidity of anastomotic stricture and ileus didn’t show any statistical difference between the two groups. Conclusion The combined-therapy st rategy ofcolorectal cancer has showed a priority to routine ways , not only the more reasonable time arrangement for therapy , but also the more satisfied surgical outcomes. However , the factors correlated to the efficacy of the MDT model are not clear ; the MDT model still needs to be improved that a morereasonable and effective perioperative MDT model may come t rue.
目的 观察替吉奥胶囊联合奥沙利铂治疗晚期结直肠癌的近期疗效和毒性反应。 方法 2011年5月－12月，将30例晚期结直肠癌患者根据体表面积来确定初始剂量，体表面积＜1.25 m2者，替吉奥胶囊40 mg/次，2次/d；体表面积1.25～1.50 m2者，替吉奥胶囊50 mg/次，2次/d；体表面积＞1.50 m2者，替吉奥胶囊60 mg/次，2次/d。早饭后和晚饭后分别口服1次，第1～4天服用奥沙利铂注射液 130 mg/ m2，静脉滴注，第1、21天重复，此为1个月周期。连用2周期后，按美国国立癌症研究所拟定的药物不良反应的分级评价标准3.0版本评价不良反应，按实体瘤治疗疗效评价标准评价疗效。 结果 30例患者中，完全缓解1例（3.3%），部分缓解7例（23.3%），稳定12例（40%），进展10例（33.3%），疾病控制率为66.6%。不良反应主要是血液学毒性、胃肠道反应、皮肤色素沉着及外周神经毒性；1例Ⅳ度骨髓抑制，3例3度贫血，2例3度腹泻，2例3度皮肤色素沉着，2例3度恶心、呕吐，其余且均在Ⅰ～Ⅱ度骨髓抑制。 结论 替吉奥胶囊联合奥沙利铂方案治疗晚期结直肠癌可获得较高的疾病控制率，不良反应可控。